BAM
IMNM icon

Blueshift Asset Management’s Immunome IMNM Stock Holding History

Blueshift Asset Management’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$223K Buy
+10,534
New +$225K 0.05% 472

Other funds holding IMNM

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Blueshift Asset Management's IMNM Position: Q2 2026 in Review

Blueshift Asset Management opened a new position in Immunome (IMNM) in Q2 2026: 10,534 shares worth $223K. The stake represents 0.05% of the portfolio and ranks #472 among its holdings.

202 funds tracked by Wall St. Rank hold IMNM as of Q2 2026.

  • Blueshift Asset Management held 10,534 shares of Immunome worth $223K as of Q2 2026.
  • Immunome was a new Blueshift Asset Management position in Q2 2026.
  • Immunome made up 0.05% of Blueshift Asset Management's portfolio in Q2 2026, its #472 holding.
  • 202 funds tracked by Wall St. Rank held Immunome as of Q2 2026.

Based on Blueshift Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.